Owing to its antagonistic relationship with TGF‐β, BMP‐7 has emerged as a promising therapeutic candidate, with the potential to alleviate fibrotic changes in the TM, restore normal aqueous humor outflow, and reduce the risk of glaucoma. Here, TGFB1 is linked to glaucoma.